Advertisement

Topics

Search Results for "Reminder Sample Letter Prostate Cancer"

09:30 EST 7th December 2016 | BioPortfolio

Matching Channels

Prostate Cancer in Men

Prostate cancer is the most common cancer in men in the UK; affecting 250,000 men. Risk factors for prostate cancer include age (average age at diagnosis is 70), a family history and a Caribbean or ...

Prostate Cancer Cellular Vaccine rDNA

Prostate specific membrane antigen PSMA

Prostate-specific membrane antigen (PSMA) is a transmembrane protein commonly found on the surface of late-stage and metastatic prostate cancer and a well-known imaging biomarker for staging and monit...

Abiraterone Acetate - Zytiga

On April 28, 2011, the US Food and Drug Administration (FDA) approved Zytiga (abiraterone acetate), for use in combination with prednisone for the second-line treatment of castration-resistant prost...

Prostate Mab

Matching News

MRI feasible for predicting prostate CA in unselected sample

(HealthDay)—Prostate multiparametric magnetic resonance imaging (MRI) is feasible for predicting prostate cancer in an unselected sample of the general population, according to a study published in ...

Radioactive prostate cancer drug given approval for NHS use – The Independent

The IndependentRadioactive prostate cancer drug given approval for NHS useThe IndependentA radioactive drug, similar to that which killed Russian former spy Alexander Litvinenko has been approved as a...

What you need to know about prostate cancer – BT.com

BT.comWhat you need to know about prostate cancerBT.comProstate cancer kills 10,000 men a year and by 2030 it will be the most common of all cancers in the UK. We take a look at the signs and symptoms...

SEER Data Show Early Prostate Cancer Diagnoses Continue to Drop

Early-stage prostate cancer diagnoses have continued to decrease since the US Preventive Services Task Force (USPSTF) recommended against routine prostate specific antigen (PSA) testing in 2012, accor...

PSA: The Prostate Cancer Screening Test

Prostate cancer is the second most common cancer in American men, following skin cancer. One in every seven men will be diagnosed with this form of cancer in his lifetime; with the average age of diag...

For early prostate cancer, a watchful eye is just as good as treatment – Ars Technica

Ars TechnicaFor early prostate cancer, a watchful eye is just as good as treatmentArs TechnicaIn the wake of a cancer diagnosis, deciding to sit back and see how things play out may seem like a ballsy...

Prostate cancer diagnoses down from 2011 to 2013

(HealthDay)—From 2011 to 2013 there was a decrease in prostate cancer (PC) diagnoses, especially for younger men and low-risk disease, according to a research letter published online June 23 in JAMA...

New study shows the importance of family history in the risk of developing prostate cancer

Although it is already known that men with prostate cancer in the family have a higher risk of the cancer themselves, this marks the first time ever that researchers have estimated the risk of develop...

Matching PubMed Articles

Gene expression profile of FVII and AR in primary prostate cancer.

The ectopic expression of coagulation Factor VII has been shown in various cancers. Recently, F7 gene has been identified as a direct target of the androgen receptor in breast cancer. In this study, w...

Digoxin and prostate cancer survival in the Finnish Randomized Study of Screening for Prostate Cancer.

Protective effects have been suggested for digoxin against prostate cancer risk. However, few studies have evaluated the possible effects on prostate cancer-specific survival. We studied the associati...

MicroRNA-103 suppresses tumor cell proliferation by targeting PDCD10 in prostate cancer.

It is known that microRNAs (miRNAs) are a class of small, non-coding RNAs that act as key regulators in various physiological and pathological processes. However, the regulatory mechanisms involving m...

Immune Checkpoint Therapies in Prostate Cancer.

Advanced prostate cancer is the second leading cause of death from cancer in the United States. In the era of cancer immunotherapy, it was the first malignancy to demonstrate improved survival with a ...

Vitamin D, PTH, and calcium in relation to survival following prostate cancer.

Epidemiological studies suggest that low levels of vitamin D constitute a risk factor for prostate cancer. However, the results are conflicting, perhaps because prostate cancer is a very heterogeneous...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement